Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: The EP-SEASON study
Jia‐Wei Lv(Sun Yat-sen University), Ying Sun(Key Laboratory of Guangdong Province), Yu‐Pei Chen(Sun Yat-sen University), Li Lin(Sun Yat-sen University), XinLei Ai(Sun Yat-sen University), Guan‐Qun Zhou(Sun Yat-sen University), Ling‐Long Tang(Sun Yat-sen University), Yan‐Ping Mao(Sun Yat-sen University), Jun Ma(Shanghai Institute of Technology), Lulu Zhang(Xijing Hospital), Rui Guo(Sun Yat-sen University), Lei Chen(Kunming University of Science and Technology), Zhi‐Xuan Li(Sun Yat-sen University), Wen‐Fei Li(Sun Yat-sen University), Ling-Xin Xu(Sun Yat-sen University), Ting-Qiu Quan(Sun Yat-sen University), Shi-Yue Wu(Sun Yat-sen University), Meng-Yu Hao(Sun Yat-sen University), Zi-Cheng Zhen(Sun Yat-sen University), Denghui Wei(Yibin University), Chen‐Fei Wu(Sun Yat-sen University), Jibin Li(State Key Laboratory of Pollution Control and Resource Reuse)
Cited by 64
Related Papers
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
A Metagenomic Approach to Characterization of the Vaginal Microbiome Signature in Pregnancy
|PLoS ONE|2012|703
Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma
|Cell Research|2020|483
RAB31 marks and controls an ESCRT-independent exosome pathway
|Cell Research|2020|472